Fani M - Search Results

1

First clinical evidence that imaging with somatostatin receptor antagonists is feasible.

Wild D, Fani M, Behe M, Brink I, Rivier JE, Reubi JC, Maecke HR, Weber WA. Wild D, et al. Among authors: fani m. J Nucl Med. 2011 Sep;52(9):1412-7. doi: 10.2967/jnumed.111.088922. Epub 2011 Aug 18. J Nucl Med. 2011. PMID: 21852357 Free article.

2

Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications.

Gaonkar RH, Schmidt YT, Mansi R, Almeida-Hernandez Y, Sanchez-Garcia E, Harms M, Münch J, Fani M. Gaonkar RH, et al. Among authors: fani m. J Med Chem. 2023 Jul 13;66(13):8484-8497. doi: 10.1021/acs.jmedchem.3c00131. Epub 2023 Jun 16. J Med Chem. 2023. PMID: 37328158 Free PMC article.

3

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.

Fani M, André JP, Maecke HR. Fani M, et al. Contrast Media Mol Imaging. 2008 Mar-Apr;3(2):67-77. doi: 10.1002/cmmi.232. Contrast Media Mol Imaging. 2008. PMID: 18383558 Free article. Review.

4

In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.

Forrer F, Chen J, Fani M, Powell P, Lohri A, Müller-Brand J, Moldenhauer G, Maecke HR. Forrer F, et al. Among authors: fani m. Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1443-52. doi: 10.1007/s00259-009-1120-2. Epub 2009 Apr 7. Eur J Nucl Med Mol Imaging. 2009. PMID: 19350237 Clinical Trial.

5

Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates.

Fani M, Wang X, Nicolas G, Medina C, Raynal I, Port M, Maecke HR. Fani M, et al. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):108-19. doi: 10.1007/s00259-010-1597-8. Epub 2010 Aug 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 20799032

6

Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.

Fani M, Mueller A, Tamma ML, Nicolas G, Rink HR, Cescato R, Reubi JC, Maecke HR. Fani M, et al. J Nucl Med. 2010 Nov;51(11):1771-9. doi: 10.2967/jnumed.110.076695. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956465 Free article.

7

PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.

Fani M, Del Pozzo L, Abiraj K, Mansi R, Tamma ML, Cescato R, Waser B, Weber WA, Reubi JC, Maecke HR. Fani M, et al. J Nucl Med. 2011 Jul;52(7):1110-8. doi: 10.2967/jnumed.111.087999. Epub 2011 Jun 16. J Nucl Med. 2011. PMID: 21680701 Free article.

8

Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.

Dumont RA, Deininger F, Haubner R, Maecke HR, Weber WA, Fani M. Dumont RA, et al. Among authors: fani m. J Nucl Med. 2011 Aug;52(8):1276-84. doi: 10.2967/jnumed.111.087700. Epub 2011 Jul 15. J Nucl Med. 2011. PMID: 21764795 Free article.

9

Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.

Cescato R, Waser B, Fani M, Reubi JC. Cescato R, et al. Among authors: fani m. J Nucl Med. 2011 Dec;52(12):1886-90. doi: 10.2967/jnumed.111.095778. Epub 2011 Nov 8. J Nucl Med. 2011. PMID: 22068898 Free article.

10

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR. Abiraj K, et al. Among authors: fani m. J Nucl Med. 2011 Dec;52(12):1970-8. doi: 10.2967/jnumed.111.094375. Epub 2011 Nov 11. J Nucl Med. 2011. PMID: 22080443 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters